MAITREYA MEDICARE Stock Price Today (NSE: MAITREYA)

MAITREYA MEDICARE

MAITREYAHospital
163.15+0.00 (+0.00%)
Market Closed

Fundamental Score

...

MAITREYA MEDICARE Share Price — Live NSE/BSE Price, Fundamentals & Analysis

MAITREYA MEDICARE share price today is 163.15, up +0.00% on NSE/BSE as of 2 June 2026. MAITREYA MEDICARE (MAITREYA) is a Small-cap company in the Hospital sector with a market capitalisation of 167.84 (Cr). The 52-week high for MAITREYA share price is 298.80 and the 52-week low is 161.00. At a P/E ratio of 1049.00x, MAITREYA is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 7.17% and a debt-to-equity ratio of 0.14.

MAITREYA MEDICARE Share Price Chart — NSE/BSE Historical Performance

No data
High
195.00
Low
161.00
Volume
2.4K
Change
-7.31%

MAITREYA MEDICARE share price chart: -7.31% return over the past month. 52-week high ₹298.80, 52-week low ₹161.00.

MAITREYA MEDICARE — Last 10 Trading Days

DateOpenHighLowCloseVolume
161.65167.90161.65164.801.60K (Cr)
174.50174.50174.50174.50400.00 (Cr)
173.00176.00170.65175.302.40K (Cr)
175.20181.00171.05175.052.80K (Cr)
176.90183.50176.90180.003.20K (Cr)
174.00182.90174.00182.902.00K (Cr)
174.00187.85174.00177.002.40K (Cr)
195.00195.00180.60180.601.60K (Cr)
161.00184.00161.00177.805.60K (Cr)
184.05184.05183.95183.95800.00 (Cr)

MAITREYA MEDICARE — Last 12 Months Price History

MonthOpenHighLowCloseChange
174.00187.85161.65164.80-5.29%
184.05195.00161.00180.60-1.87%
185.10205.00162.05176.50-4.65%
206.00215.00191.60200.00-2.91%
213.75244.00190.90192.40-9.99%
247.50268.50200.00218.90-11.56%
247.00292.95225.90256.60+3.89%
232.00267.00224.30237.00+2.16%
242.25285.00228.00229.20-5.39%
237.00275.00220.00254.85+7.53%
259.75279.70235.20241.60-6.99%
278.85298.80256.25266.00-4.61%

AI Research Briefing

Powered by Gemini · 2026-04-09

Maitreya Medicare's financials are deteriorating rapidly, and the market's growth expectations are detached from reality.

Research Confidence
8.0/10High
MICRO-CAP DARK HORSEConsolidation - 1M: 4.56%, 3M: -1.04%, 6M: -6.97% [cite: brief]Expensive - P/E of 1049x vs industry P/E of 52.84x [cite: brief]

WHAT'S HAPPENING NOW

Maitreya Medicare reported a concerning set of quarterly results on April 2, 2026. Net profit plummeted to ₹-1.07 crore, a 167.72% QoQ decrease and a staggering 146.52% YoY decline. While revenue saw a slight 5.12% QoQ increase to , operating profit tanked by 137.05% QoQ to ₹-0.93 crore.

CORE STORY

Maitreya Medicare is being priced as a high-growth turnaround story in the SME hospital space, despite its micro-cap nature and recent poor performance. The market seems to be overlooking current financial struggles, focusing instead on potential future expansion and service offerings.

Why Now
  • Upcoming Valsad hospital
  • Expansion into 18 specialities
  • Micro-cap turnaround story
Potential Catalysts
  • Successful commissioning of Valsad hospital
  • Significant increase in bed occupancy rates
  • Attainment of profitability in next two quarters
Key Risks
  • Micro-cap liquidity risk
  • Extremely high P/E ratio
  • Negative free cash flow
  • Recent massive profit decline
Institutional Activity

FII holdings decreased by 0.01% [cite: brief]

Macro Context

The Indian hospital sector is growing, but faces increasing cost pressures and regulatory scrutiny.

Cash Flow Quality

No - Free Cash Flow 5Y: ₹-0.26 Cr [cite: brief]

3–6 Month Outlook

The next 6 months will be critical to see if the company can turn around its performance. Without significant improvement, the stock is likely to underperform.

Primary Thesis Risk

Inability to achieve profitability and manage working capital will lead to collapse.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

7.17%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

10.77%

Returns generated on total capital deployed

Good

Oper. Profit Margin (5Y Avg)

12.21%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

MAITREYA MEDICARE Valuation Check

Poor

Price to Earnings (P/E)

1049.00x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

52.84x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

73.11%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-102.40%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-2.71%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.14x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

2.28x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-0.26 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

MAITREYA MEDICARE Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MAITREYA across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Conservative Debt Levels (D/E: 0.14)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Balanced Promoter Holding (73.11%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

6 factors identified

Below-Average Return on Equity (7.17%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Premium Valuation Risk (P/E: 1049.00x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-102.40%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Interest Coverage (2.28x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-0.26 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

MAITREYA MEDICARE vs Hospital Peers

Peer Comparison - Hospital

Compare MAITREYA MEDICARE with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
16/100
163
₹167.84
1049.0
Average
7.17%
Poor
10.77%
Average
0.1
Excellent
0.00%
69.1/100
993
₹109416.28
77.7
Average
12.72%
Average
14.88%
Average
0.3
Excellent
80.50%
Excellent
46.01%
Excellent
0.13%
50.2/100
8273
₹104825.94
62.7
Average
18.42%
Good
16.64%
Good
0.9
Good
33.72%
Excellent
14.15%
Good
0.26%
55.6/100
961
₹68301.24
67.8
Average
10.13%
Average
11.96%
Average
0.3
Excellent
70.31%
Excellent
10.93%
Good
0.11%
62.2/100
1920
₹39051.19
45.9
Average
24.22%
Excellent
20.75%
Excellent
0.6
Good
43.49%
Excellent
11.88%
Good
0.24%
15.4/100
741
₹34688.15
94.5
Average
8.26%
Poor
10.68%
Average
0.5
Excellent
-7.24%
Poor
-13.71%
Poor
0.75%
61/100
1208
₹33498.00
56.0
Average
16.48%
Good
19.74%
Good
0.3
Excellent
70.15%
Excellent
19.73%
Excellent
0.04%
45.1/100
784
₹27605.54
84.0
Average
18.48%
Good
15.00%
Good
1.4
Average
25.01%
Excellent
22.01%
Excellent
0.00%
51.2/100
480
₹16844.04
145.2
Average
4.76%
Poor
9.99%
Poor
0.5
Good
41.72%
Excellent
26.38%
Excellent
0.00%
54.6/100
1377
₹13410.38
52.8
Average
17.43%
Good
18.69%
Good
0.5
Good
33.66%
Excellent
16.08%
Excellent
0.23%
36.4/100
660
₹10474.40
296.2
Average
5.14%
Poor
8.56%
Poor
1.9
Average
19.34%
Excellent
15.22%
Excellent
0.00%

MAITREYA MEDICARE Quarterly Performance

Latest quarterly metrics for MAITREYA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-2.71%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-102.40%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

MAITREYA MEDICARE Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MAITREYA — calculated from daily price history

30RSI 14
Neutral — RSI 30

Momentum is balanced — neither overbought nor oversold.

SMA 50
214
▼ Price below SMA 50 — Short-term bearish
SMA 200
255
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
3K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

MAITREYA MEDICARE Financial Statements

Annual income statement, balance sheet and cash flow for MAITREYA MEDICARE (MAITREYA) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for MAITREYA MEDICARE

About MAITREYA (MAITREYA MEDICARE)

MAITREYA MEDICARE (MAITREYA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current mar...ket capitalisation of ₹167.84 (Cr). MAITREYA MEDICARE has delivered a Return on Equity (ROE) of 7.17% and a ROCE of 10.77%. The debt-to-equity ratio stands at 0.14, reflecting the company's capital structure. Investors tracking MAITREYA share price can monitor key metrics including P/E ratio, promoter holding of 73.11%, and quarterly earnings growth.

Company Details

Symbol:MAITREYA
Industry:Hospital
Sector:Hospital
Website:N/A

MAITREYA Share Price: Frequently Asked Questions

What is the current share price of MAITREYA MEDICARE?

MAITREYA MEDICARE (MAITREYA) trades at ₹163.15 on NSE. Market cap ₹167.84 (Cr). Educational data only.

What is the P/E ratio of MAITREYA MEDICARE?

MAITREYA MEDICARE has a P/E of 1049.00x vs industry average 52.84x.

What is the Bull Run score for MAITREYA MEDICARE?

MAITREYA MEDICARE has a Bull Run score of 16/100 based on 25+ financial parameters.

Does MAITREYA MEDICARE pay dividends?

MAITREYA MEDICARE has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of MAITREYA MEDICARE?

MAITREYA MEDICARE has ROE of 7.17%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of MAITREYA MEDICARE?

MAITREYA MEDICARE has debt-to-equity of 0.14.

Is MAITREYA MEDICARE a good investment?

Bull Run gives MAITREYA MEDICARE a score of 16/100. This is not investment advice — consult a SEBI-registered advisor.